onAIRR 4: Understanding and engineering immune repertoires with

On AIRR - Immune receptors in the clinic

onAIRR 4: Understanding and engineering immune repertoires with Dr. Jacob Glanville

Listen now

Description

Dr. Jacob Glanville is founder and CEO of Centivax and founder of Distributed Bio, acquired by Charles River in 2021. His work focuses on understanding and engineering the repertoires of T and B cells to improve the response to pathogens. In this episode we discuss how to analyze receptor specificity and use this to create therapeutic antibodies and optimize vaccine response. AIRR Community Meeting VI: “Exploring New Frontiers”: https://www.antibodysociety.org/the-airr-community/meetings/airr-community-meeting-vi-exploring-new-frontiers iReceptor+ Seminar Series: http://www.ireceptor-plus.com/news-and-events/seminars Comments are welcome to the inbox of [email protected] or on social media under the hashtag #onAIRR. Further information can be found here: https://www.antibodysociety.org/the-airr-community/airr-c-podcast

More Episodes

See all »

On AIRR 15: Germline databases or adventures into the allelic underworld with Dr. Corey Watson and Dr. William Lees

Dr. Corey Watson is Associate Professor at University of Louisville. His work focuses on characterising and cataloguing antibody genetic diversity in human and mouse to better understand disease susceptibility and clinical health outcomes. Dr. William Lees is a researcher at University of London....

Published 10/30/23

On AIRR - Immune receptors in the clinic

Published 10/30/23

On AIRR 14: Data protection and data sharing with Alexander Bernier

Alexander Bernier BCL, JD, LLM, SJD (Candidate) is a Montreal-based lawyer, and a doctoral candidate at the University of Toronto Faculty of Law. His work aims to give scientists a range of compliant data sharing designs that scientists can implement in different situations. In this episode, we...

Published 08/06/23